DAFTAR PUSTAKA

1. Behrman R.E., Kliegman R.M., Jenson H.B., Nelson, 2004

2. William W. Hay Jr, et al, Current Pediatrics Diagnosis & Treatment, Mcgraw hill, 2004
3. Karen Seiter, MD; Chief Editor: Emmanuel C Besa, MD, Acute Lymphoblatic Leukemia,
Medscape, accessed 26 November 2013. Available from:
http://emedicine.medscape.com/article/207631-overview
4. Lihteh Wu, MD; Chief Editor: Hampton Roy Sr, MD, Leukemias, Medscape, accessed 26
November 2013. Available from: http://emedicine.medscape.com/article/1201870overview
5. Windiastuti E., Mulawi C., Sari Pediatri, Vol. 4, No. 1, Juni 2002: 31 35
6. Cynthia C. Chernecky, Kathleen Murphy-Ende Hyperleukocytosis in Childhood
Leukemia in Acute Care Oncology Nursing Elsevier Health Sciences, 13 Mei 2011 pg
306-310.
7. Susumu Inoue, MD; Chief Editor: Robert J Arceci, MD, PhD , Leukocytosis ,Medscape,
accesed at 30 November 2013 . Available from:
http://emedicine.medscape.com/article/956278-overview#a0199
8. Lanzkowsky P., Manual of Pediatric Hematology and Oncology, Elsevier Inc, 5th
Edition , 2010
9. Cashen A.F., Tine B.V, White blood cell disorders : Leukopenia and leukocytosis in The
Washington Manual of Hematology and Oncology Subspecialty Consult, Lippincott
Williams & Wilkins, 2012
10. Porcu P, Farag S, Marcucci G, Cataland SR, Kennedy MS, Bissell M.
Leukocytoreduction for acute leukemia. Ther Apher 2002; 6:1523, Accessed 26
November 2013. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11886572
11. Porcu P, Cripe LD, Ng EW, et al. Hyperleukocytic leukemias and leukostasis: a review
of pathophysiology, clinical presentation, and management. Leuk Lymphoma 2000; 39:1
18.
12. Litchman MA, Heal J, Rowe JM. Hyperleukocytic leukaemia. Rheological and clinical
features and management. Balliers Clinical Haematology 1987;1:725-46.
13. Jain R, Bansal D, Marwaha RK. Hyperleukocytosis: Emergency management. Indian J
Pediatr. 2013;80:1448.
14. Grund FM, Armitage JO, Burns P. Hydroxyurea in the prevention of the effects of
leukostasis in acute leukemia. Arch Intern Med. 1977;137:12467.
15. Buchem V.MA, te Velde J, Willemze R, Spaander PJ. Leucostasis, an underestimated
cause of death in leukaemia. Blut 1988; 56:3944.
16. McKee LC, Collins RD. Intravascular leukocyte thrombi and aggregates as a cause of
morbidity and mortality in leukemia. Medicine (Baltimore) 1974; 53:463478.
17. Majhail N.S., Lichtin A.E., Acute leukemia with a very high leukocyte count:
confronting a medical emergency. Cleveland Clin J Med 2004;71:633-7.
18. Singh H., Prasad BNS., Jagdish, A Batra Hyperleukocytosis Associated Pulmonary
Leukostasis in Acute Leukaemia, accessed 26 November 2013. Available from :
www.japi.org/may2006/CR-405.pdf

19. Buchem M.A, Wondergem J.H, Kool L.J, et al. Pulmonary leukostasis: radiologicpathologic study. Radiology 1987; 165:739741.
20. Romano M.J, Weber M.D, Weisse M.E, Siu B.L. Pertussis pneumonia, hypoxemia,
hyperleukocytosis, and pulmonary hypertension: Improvement in oxygenation after a
double volume exchange transfusion. Pediatrics. 2004;114:e2646.
21. Underwood M.A, Wartell A.E, Borghese R.A, Hyperleukocytosis in a premature infant
with intrauterine herpes simplex encephalitis. J Perinatol. 2012;32:46972.
22. Dr Donna Lancaster Policy for the Management of Hyperleucocytosis in Childhood
Leukaemia Royal Marsden NHS Foundation Trust
23. Berg J, Vincent PC, Gunz FW. Extreme leucocytosis and prognosis of newly diagnosed
patients with acute non-lymphocytic leukaemia. Med J Aust 1979; 1:480482.
24. Flasshove M, Schuette J, Sauerwein W, Hoeffken K, Seeber S. Pulmonary and cerebral
irradiation for hyperleukocytosis in acute myelomonocytic leukemia. Leukemia 1994;
8:1792.
25. Butler RW, Hill JM, Steinherz PG, Meyers PA, Finlay JL. Neuropsychologic effects of
cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood
cancer. J Clin Oncol 1994; 12:26212629.
26. Porcu P, Danielson CF, Orazi A, Heerema NA, Gabig TG, McCarthy LJ. Therapeutic
leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of
cytoreduction and early mortality rate. Br J Haematol 1997; 98:433436.
27. Giles FJ, Shen Y, Kantarjian HM, et al. Leukapheresis reduces early mortality in patients
with acute myeloid leukemia with high white cell counts but does not improve long-term
survival. Leuk Lymphoma 2001; 42:6773.
28. Basade M, Dhar AK, Kulkarni SS, et al. Rapid cytoreduction in childhood leukemic
hyperleukocytosis by conservative therapy. Med Pediatr Oncol 1995; 25:204207.
29. Bunin NJ, Pui CH. Differing complications of hyperleukocytosis in children with acute
lymphoblastic or acute nonlymphoblastic leukemia. J Clin Oncol 1985; 3:15901595.
30. Eguiguren JM, Schell MJ, Crist WM, Kunkel K, Rivera GK. Complications and outcome
in childhood acute lymphoblastic leukemia with hyperleukocytosis. Blood 1992; 79:871
875.
31. Tan D, Hwang W, Goh Y.T., Therapeutic Leukapharesis in Hyperleukocytic Leukemias,
2005, Vol 34 No. 3, accessed 27 November 2013. Available from :
www.annals.edu.sg/pdf/34volno3200504/v34n3p229.pdf
32. Irken G., Haldun H.O., Oniz, Cetingul N., Vergin C., Atabay B, Gulen H., Turker M.,
Kantar M., Ylmaz S, Hyperleukocytosis in childhood acute lymphoblastic leukemia:
complications and treatment outcome Turk J Hematol 2006; 23:142-146.
33. William Blum, and Pierluigi Porcu, Therapeutic Apheresis in Hyperleukocytosis and
Hyperviscosity Syndrome, 2007, accessed 27 November 2013. Available from:
www.medicine.wisc.edu/~williams/apheresis_review.pdf
34. Lichtman et al. Hyperleukocytic leukemias: rheological, clinical, and therapeutic
considerations. Blood(1982); 60:279-283.
35. Pediatric Nephrology(1995) 9:206-212 DP Jones, H Mahmoud, RW Chesney - Pediatric
Nephrology, 1995

36. Denish Mika, Sabrina Ahmad, C Guruvayoorappan, Tumour Lysis Syndrome:

Implications for Cancer Therapy, Asian Pacific Journal of Cancer Prevention, Vol 13,
2012
37. Cairo MS, Bishop M (2004). Tumour lysis syndrome: new therapeutic strategies and
classification. Br J Haematol, 127, 3-11.